Back

We can stop oral anticoagulation in moderate risk patients after successful ablation - PRO

17 March 2019 (08:37 - 08:45)
Organised by:
Congress Presentation Part of: Controversies in atrial fibrillation ablation Treatment EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Richard Schilling

St Bartholomew's Hospital, London (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
Opening question
Slides Video
Presentation thumbnail
We can stop oral anticoagulation in moderate risk patients after successful ablation - CONTRA
Professor J. Merino (Madrid, ES)
Slides Video
Presentation thumbnail
Rebuttal - PRO
Presentation thumbnail
Rebuttal - CONTRA
Presentation thumbnail
Chairperson conclusion & closing question
Slides Video

Access the full session

Session thumbnail
Controversies in atrial fibrillation ablation

The Event

Event poster

EHRA 2019

17 March 2019 08:37 CET
You may be interested in
thumbnail
Congress Presentation
Exploring the feasibility of discontinuing oral anticoagulant therapy in post-ablation atrial fibrillation patients with low stroke risk: a conceptual inquiry
1 April 2025
thumbnail
Congress Session
Choose the right workflow for your AF patients - Live cases with Varipulse, QDOT and Optrell
31 March 2025
thumbnail
Congress Presentation
Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation or left sided atrial tachycardia in patients on oral anticoagulation.
16 April 2023
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources